Nomura Holdings Inc Esperion Therapeutics, Inc. Call Options Transaction History

Nomura Holdings Inc

  • $41.1 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2018

Feb 14, 2019
BUY
$36.99 - $59.11 $1.47 Million - $2.35 Million
39,800 Added 23.36%
210,200 $9.65 Million
Q3 2018

Nov 14, 2018
BUY
$40.74 - $51.41 $3.68 Million - $4.65 Million
90,400 Added 113.0%
170,400 $7.72 Million
Q2 2018

Aug 14, 2018
BUY
$36.2 - $76.4 $2.22 Million - $4.68 Million
61,200 Added 325.53%
80,000 $2.93 Million
Q1 2018

May 14, 2018
BUY
$65.94 - $80.76 $1.24 Million - $1.52 Million
18,800 New
18,800 $1.36 Million

Others Institutions Holding ESPR

# of Institutions
207
Shares Held
128M
Call Options Held
1.67M
Put Options Held
930K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $171M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email